Health Care Equipment & Services

Centene Corp. stock drops 27% in five years, highlighting negative earnings and volatile Medicaid/Medicare focus. Learn why investors should rethink its future.

Ventripoint Diagnostics: a low‑cost, bolt‑on 3‑D cardiac imaging solution that boosts accuracy, drives subscription revenue, and scales without new hardware—transforming hospital diagnostics.

BrightSpring Health Services Q4 2025 earnings reveal a 10.8 % revenue rise and 331 % EPS jump, with 2026 guidance forecasting $13.9 B revenue and $1.78 EPS—driven by AI‑powered care platforms and expanding behavioral‑health services.

Health Catalyst appoints new CEO Ben Albert amid volatile $1.73 stock; learn how the Utah‑based health‑software firm plans to stabilize its market and drive innovation.

ImExHS Limited reports FY25 results: $29 M revenue, 10 % growth, rising EBITDA, strong user engagement, and top‑end performance in the global healthcare imaging market.

Explore HCA Healthcare’s 2026 updates: new executive incentive program, conference plans, and historic growth—key insights for investors and health‑care stakeholders.

Explore IDEXX Laboratories’ high valuation, leadership shifts, AI risks, and tariff impacts—find out if the diagnostic leader can sustain growth.

Pentixapharm Holding AG stock hits €2.175 on Xetra, amid mid‑year volatility but steady clinical progress—investors eye next breakthrough for future upside.

Explore Cyclopharm Ltd’s radiopharmaceutical strategy—focus on lung & cancer imaging, current market stats, and future growth prospects.

MedMira Inc. reports a tough quarter, with its TSX stock hovering near $0.07 and a negative P/E of –12.07, yet it continues pushing next‑generation diagnostic tech worldwide.